798
S. Bourrain et al.
LETTER
stability over the corresponding triflates. The new bifunc-
tional reagent 1-methyl-3-bromo-pyrazol-5-yl nonaflate
(13) undergoes highly chemoselective Pd-catalysed cou-
pling to the nonaflate functionality, allowing sequential,
regioselective introduction of two aryl substituents in a
short and efficient synthesis.
Acknowledgment
We thank Dr Michael Reader for the preparation of compound 10,
and Kevin Merchant and Dr Linda Keown for helpful discussions.
IC dedicates this paper to his colleagues and friends at MSD.
References
(1) New address: I. Collins, CRUK Centre for Cancer
Therapeutics, The Institute for Cancer Research, 15
Cotswold Road, Sutton, Surrey SM2 5NG, U.K.
Compound 3: MeNHNH2 (1.0 mL) was added to a stirred solution
of 1 (2.75 g) in MeOH (20 mL) at r.t. After 18 h the solvent was re-
duced in volume to ca. 10 mL and the white solid 3 was collected
(1.07 g, 43%). Chromatography of the mother liquors, eluting with
EtOAc–isohexane (2:3 to 4:1), gave further 3 (1.07 g, 41%) and 4
(0.11 g, 4%). 3: 1H NMR (400 MHz, d6-DMSO): d = 3.55 (3 H, s),
5.77 (1 H, s), 7.17 (2 H, dd, J = 9, 9 Hz), 7.72 (2 H, dd, J = 9, 6 Hz),
11.05 (1 H, s). 13C NMR (100 MHz, d6-DMSO): d = 33.1, 83.0,
115.1 (d, J = 22 Hz), 126.3 (d, J = 8 Hz), 130.5, 136.4, 152.8, 161.5
(d, J = 245). MS (ES+): m/z = 193 (M + H)+.
(2) For reviews of the synthesis and biological activity of N-
alkyl pyrazoles see: (a) Elguero, J. Comprehensive
Heterocyclic Chemistry, Vol. 5; Potts, K. T., Ed.; Pergamon:
Oxford, 1984, 167. (b) Elguero, J. Comprehensive
Heterocyclic Chemistry II, Vol. 3; Katritzky, A. R.; Rees, C.
W.; Scriven, E. F. V., Eds.; Pergamon: Oxford, 1996, 1.
(3) For examples of Pd-catalysed cross-coupling to N-alkyl- or
N-benzyl-3(5)-halopyrazoles see: (a) Tretyakov, E. V.;
Knight, D. W.; Vasilevsky, S. F. J. Chem. Soc., Perkin
Trans. 1 1999, 3713. (b) Paulson, A. S.; Eskildsen, J.;
Vedso, P.; Begtrup, M. J. Org. Chem. 2002, 67, 3904.
(c) Cottineau, B.; Chenault, J. Synlett 2002, 769. (d) Balle,
T.; Andersen, K.; Vedso, P. Synthesis 2002, 1509.
(e) Eskildsen, J.; Ostergaard, N.; Vedso, P.; Begtrup, M.
Tetrahedron 2002, 58, 7635.
(4) For examples of Pd-catalysed cross-coupling to N-aryl-3(5)-
halopyrazoles see: (a) Wang, X.-J.; Tan, J.; Grozinger, K.
Tetrahedron Lett. 2000, 41, 4713. (b) Organ, M. G.; Mayer,
S. J. Comb. Chem. 2003, 5, 118.
(5) Regan, J.; Breitfelder, S.; Crillo, P.; Gilmore, T.; Graham, A.
G.; Hickey, E.; Klaus, B.; Madwed, J.; Moriak, M.; Moss,
N.; Pargellis, C.; Pav, S.; Proto, A.; Swinamer, A.; Tong, L.;
Torcellini, C. J. Med. Chem. 2002, 45, 2994.
(6) For a review see: Varvounis, G.; Fiamegos, Y.; Pilidis, G.
Adv. Het. Chem. 2001, 80, 73.
(7) (a) Hamper, B. C.; Kurtzweil, M. L.; Beck, P. J. Org. Chem.
1992, 57, 5680. (b) Sucrow, W.; Slopianka, M.; Vetter, H. J.
Chem. Ber. 1978, 111, 791.
(8) Hendrickson, J. B.; Hussoin, M. S. Synthesis 1989, 217.
(9) Morris, J.; Wishka, D. G. Synthesis 1994, 43.
(10) Rottlander, M.; Knochel, P. J. Org. Chem. 1998, 63, 203.
(11) Renold, P.; Madero, E.; Maetke, T. J. Chromatogr., A 2001,
908, 143.
(12) (a) Collins, I. J. Chem. Soc., Perkin Trans. 1 2000, 2845.
(b) Collins, I. J. Chem. Soc., Perkin Trans. 1 2002, 1921.
(13) Boschi, P. M.; Gozzo, A. L. US Pat. Appl. 4256902, 1981;
Chem. Abstr. 1981, 95, 7281.
Compound 4: H2O (250 mL) and MeNHNH2 (14.6 mL) were add-
ed to a solution of 2 (44.6 g) in EtOH (250 mL). The mixture was
stirred at 60 °C for 7 h, then stood at r.t. for 8 h. The white solid was
collected and rinsed with EtOAc to give the product 4 (29 g, 60%).
1H NMR (400 MHz d6-DMSO): d = 3.60 (3 H, s), 5.62 (1 H, s), 7.31
(2 H, dd, J = 9, 9 Hz), 7.53 (2 H, dd, J = 9, 6 Hz), 9.69 (1 H, s). 13
C
NMR (100 MHz, d6-DMSO): d = 36.5, 90.5, 115.6 (d, J = 21 Hz),
126.8, 130.4 (d, J = 8 Hz), 142.4, 159.8, 161.9 (d, J = 244 Hz). MS
(ES+): m/z = 193 (M + H)+.
1-Methyl-3-bromo-5-pyrazolone (12): A solution of 1116 (13.7 g)
in CH2Cl2 (40 mL) was added dropwise at 0 °C over 20 min to a
stirred solution of ethyl 3-methylhydrazinecarboxylate17 (6.9 g) and
Et3N (8.4 mL) in CH2Cl2 (110 mL). The solution was stirred at 0 °C
under N2 for 2.5 h then washed with H2O (100 mL), dried (Na2SO4)
and concentrated. The yellow oil was dissolved in THF (15 mL) and
added to stirred 1 M NaOH (120 mL) at 60 °C. After 1 h the solution
was cooled, acidified to pH 1 with concd HCl, and extracted with
CH2Cl2 (4 × 100 mL). The extracts were dried (Na2SO4) and con-
centrated. The orange solid was rinsed with boiling Et2O (2 × 20
mL) to give a yellow powder (12, 6.09 g, 62%). 1H NMR (500 MHz,
CDCl3): d = 3.33 (3 H, s), 3.47 (2 H, s). 1H NMR (400 MHz, d6-DM-
SO): d = 3.47 (3 H, s), 5.44 (1 H, s), 11.44 (1 H, s). 13C NMR (d6-
DMSO, 90 MHz): d = 33.6, 88.8, 123.1, 153.5. MS (ES+): m/z =
177, 179 (M + H)+.
Preparation of nonaflates 5, 6b and 13: NaHMDS solution (1.5 M,
THF, 1.2 equiv) was added to a stirred solution of the hydroxypyra-
zole in dry THF (0.3 M) at 0 °C under N2. After 5 min, C4F9SO2F
(1.2 equiv) was added dropwise. The mixture was stirred, warming
slowly to r.t. for 2–4 h, then diluted with 1 M HCl and extracted
with EtOAc. The extracts were dried (Na2SO4) and concentrated.
Chromatography, eluting with EtOAc–isohexane (1:9) gave the
product.
Compound 5: 1H NMR (400 MHz CDCl3): d = 3.86 (3 H, s), 6.39
(1 H, s), 7.09 (2 H, dd, J = 9, 9 Hz), 7.71 (2 H, dd, J = 9, 6 Hz).
19F NMR (376 MHz, CDCl3): d = –126.2, –121.2, –113.7, –108.3,
–81.0. MS (ES+): m/z = 475 (M + H)+.
Compound 6b: 1H NMR (400 MHz, CDCl3): d = 3.81 (3 H, s), 6.15
(1 H, s), 7.20 (2 H, dd, J = 9, 9 Hz), 7.41 (2 H, dd, J = 9, 6 Hz).
19F NMR (376 MHz, CDCl3,): d = –126.3, –121.4, –111.2, –108.9,
–81.1. MS (ES+) m/z = 475 (M + H)+.
Compound 13: 1H NMR (400 MHz, CDCl3,): d = 3.80 (3 H, s), 6.20
(1 H, s). 19F NMR (376 MHz, CDCl3,): d = –126.1, –121.1, –108.0,
–81.2. MS (ES+) m/z = 459, 461 (M + H)+.
(14) (a) Rappe, C. Arkiv Kemi 1964, 21, 503. (b) Kim, H.;
Hoffman, H. M. R. Eur. J. Org. Chem. 2000, 2195.
(15) Rappe, C.; Andersson, K. Arkiv Kemi 1965, 24, 303.
(16) Coates, R. M.; Stack, D. P. Synthesis 1984, 434.
(17) (a) Prepared by a modification of the method described by:
Zinner, G.; Gebhardt, U. Arch. Pharm. 1971, 304, 706.
(b) A solution of MeNHNH2 (26 mL) in (EtO)2CO (60 mL)
was refluxed under N2 for 46 h. The solution was distilled at
1 atm to remove EtOH, then at 10 mmHg through a vigreux
column, collecting the fraction boiling at 60–80 °C.
Chromatography, eluting with MeOH–CH2Cl2 (3:97 then
5:95) gave ethyl 2-methyl-hydrazinecarboxylate (13.5 g,
85% pure by NMR) then ethyl 3-methylhydrazine-
carboxylate (21.3 g, 93% pure by NMR).
(18) Bishop, B. C.; Brands, K. M. J.; Gibb, A. D.; Kennedy, D. J.
Synthesis 2004, 43.
Synlett 2004, No. 5, 795–798 © Thieme Stuttgart · New York